ATLAS fair value
$7.49
Below fair value · 42% discount
Cumberland Pharmaceuticals stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ
Prices as of Oct 26, 2026 · USD
$7.49
Below fair value · 42% discount
39%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Cumberland Pharmaceuticals's fair value at about $7.49 per share (reasonable range: $4.84 to $9.50). At $4.35, the stock trades 42% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Cumberland Pharmaceuticals a 39% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $2.83 and $5.21; in 9 out of 10, between $1.64 and $8.95. Estimated annual volatility is 200%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Cumberland Pharmaceuticals sits below fair value and its odds of rising over a month are somewhat worse than a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks CPIX has traded between $1.13 and $9.28. Today it is 53.1% below that high and 285% above its low.
On the business: revenue grew 17.6% year over year; net margin is 6.4%.
Its beta is 0.10: it tends to move less than the market.
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing, acquiring, and commercializing branded prescription medicines for hospital acute care and other specialized treatment settings.
Want to see everything about Cumberland Pharmaceuticals?
Get started →Plans from €3.99 a month.
About $7.49 per share according to ATLAS (reasonable range: $4.84 to $9.50). With the stock at $4.35, it is 42% below it.
39%: somewhat worse than a coin flip. In half of the simulated outcomes, CPIX ends the month between $2.83 and $5.21.
ATLAS estimates annual volatility at 200%. In a typical month, half of the outcomes end between $2.83 and $5.21.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy